Merck Stake Reduced by 4.8% Amid Cancer-Trial Success
Heritage Investors Management Corp has reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 4.8% during the second quarter, according to a recent filing with the Securities & Exchange Commission.
The firm now owns 316,592 shares of the company's stock after selling 15,875 shares during the period, which accounts for approximately 1.1% of Heritage Investors Management Corp's portfolio.
This stake is valued at $40,682,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of MRK during the second quarter.